Table 2.
Pre-existing comorbidity status of adult COVID-19 patients at Eka Kotebe General Hospital, COVID-19 Treatment Center, Addis Ababa, Ethiopia, 2021.
| Variables | Category | Status | Total (%) | |
|---|---|---|---|---|
| Death (%) | Censored (%) | |||
| Having existing comorbidity | No comorbidity | 13(4.19%) | 297(95.81%) | 310(51.5%) |
| Have at least one comorbidity | 74 (25.34%) | 218 (74.66%) | 292 (48.5%) | |
| Number of comorbidities | 1–2 | 53 (21.99%) | 188 (78.01%) | 241 (81.14%) |
| ≥3 | 22 (39.29%) | 34 (60.71%) | 56 (18.86%) | |
| Cardiac disease (CHF) | No | 54(10.09%) | 481(89.91%) | 535(88.87%) |
| Yes | 33(49.25%) | 34(50.75%) | 58(9.63%) | |
| Hypertension | No | 45 (10.42%) | 387 (89.58%) | 432 (71.76%) |
| Yes | 42 (24.71%) | 128 (75.29%) | 170 (28.24%) | |
| Diabetes mellitus | No | 37 (8.01%) | 425 (91.99%) | 462 (76.74%) |
| Yes | 50 (37.71%) | 90 (64.29%) | 140 (23.26%) | |
| Chronic lung diseases (Chronic obstructive pulmonary disease (COPD) and/or asthma) | No | 84 (14.8%) | 496 (85.525) | 580 (96.35%) |
| Yes | 3 (13.64%) | 19 (86.36%) | 22 (3.65%) | |
| HIV/AIDS | No | 81 (14.01%) | 497 (85.99%) | 578 (96.01%) |
| Yes | 6 (25%) | 18 (75%) | 24 (3.99%) | |
| Malignancy | No | 84 (14.26%) | 505 (85.74%) | 589 (97.84%) |
| Yes | 3 (23.08%) | 10 (76.92%) | 13 (2.16%) | |
| Chronic liver disease | No | 80 (13.63%) | 507 (86.37%) | 587 (97.51%) |
| Yes | 7 (46.57%) | 8 (53.33%) | 15 (2.49%) | |
| Renal diseases | No | 65 (11.55%) | 498 (88.45%) | 563 (93.52%) |
| Yes | 22 (56.41%) | 17 (43.59%) | 41 (6.81%) | |
| Chronic neurological diseases | No | 79 (13.64%) | 500 (86.36%) | 579 (96.18%) |
| Yes | 8 (34.78%) | 15 (65.22%) | 23 (3.82%) | |